Trials

Category / Pharmaceuticals & Biotech / Trials

Prima BioMed to Present at LEERINK Partners Rare Disease Roundtable

Theravance Biopharma Announces FDA Acceptance of sNDA to Expand VIBATIV(R) (telavancin) Labeling

DUBLIN, IRELAND: Company Seeks Expanded Label Supporting VIBATIV Use Against Concurrent Bacteremia in Cases of Complicated Skin and Skin Structure Infections (cSSSI) or Hospital-Acquired and Ventilator-Associated Bact ...

Threshold Pharmaceuticals Announces Presentation and Webcast at the Rodman & Renshaw Annual Global Investment Conference

SOUTH SAN FRANCISCO, CA: ...

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2%

DUBLIN, IRELAND: Represents the 13th Allowed U.S. Patent for PENNSAID 2% ...

Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference

DUBLIN, IRELAND: ...

Kadmon Corporation to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

NEW YORK, NY: ...

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid

DUBLIN, IRELAND: ...

Timothy P. Walbert Receives EY Entrepreneur Of The Year(R) 2015 Midwest Award

DUBLIN, IRELAND: ...

Marina Biotech Expands European and Canadian Patent Protection of Its SMARTICLES Nucleic Acid Delivery Technology

BOTHELL, WA: Company to Present at the Partnering Forum During the 2015 BIO International Convention ...

SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China

FOSTER CITY, CA and GEORGE TOWN, GRAND CAYMAN: Once-Daily, Dual Mechanism Antibiotic Possesses Profile to Play Key Role in Global Fight Against Antimicrobial Resistance ...

Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China

GEORGE TOWN, GRAND CAYMAN and FOSTER CITY, CA: Once-Daily, Dual Mechanism Antibiotic Possesses Profile to Play Key Role in Global Fight Against Antimicrobial Resistance ...

Threshold Pharmaceuticals Announces Presentation and Webcast at the Jefferies 2015 Healthcare Conference

SOUTH SAN FRANCISCO, CA: ...

SciClone to Present at Jefferies 2015 Global Healthcare Conference on June 3, 2015

FOSTER CITY, CA: ...

Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2015 Financial Results

SOUTH SAN FRANCISCO, CA: ...

Theravance Biopharma, Inc. Reports First Quarter 2015 Financial Results

GEORGE TOWN, GRAND CAYMAN: VIBATIV(R) Commercial Activities Gaining Momentum; TD-4208 Phase 3 Program to Commence Second Half 2015; New Product Candidates Advancing Towards the Clinic; Lowering Operating Loss Guidance for 2015 ...

Corcept Therapeutics Announces First Quarter 2015 Results and Provides Corporate Update

MENLO PARK, CA: ...

Horizon Pharma plc Announces Waiver of Financing Proceeds Condition

DUBLIN, IRELAND and BRISBANE, CA: ...

Linkage Biosciences Partners With Italian Distributor

SAN FRANCISCO, CA: ...

Genetic Technologies Announces: Additional Breast Health Centres to Begin Offering BREVAGenplus(R)

MELBOURNE, AUSTRALIA: ...

Threshold Pharmaceuticals to Host Analyst and Investor Day on April 24 in New York City

SOUTH SAN FRANCISCO, CA: ...

Page 3 von 9: 1 2 3 4 5 6 7 8 9

All members:	10 667
Register today:	0
Register yesterday:	0
Members online:	0
Guests online:	297

Trials

Category / Pharmaceuticals & Biotech / Trials

Prima BioMed to Present at LEERINK Partners Rare Disease Roundtable

Theravance Biopharma Announces FDA Acceptance of sNDA to Expand VIBATIV(R) (telavancin) Labeling

Threshold Pharmaceuticals Announces Presentation and Webcast at the Rodman & Renshaw Annual Global Investment Conference

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2%

Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference

Kadmon Corporation to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid

Timothy P. Walbert Receives EY Entrepreneur Of The Year(R) 2015 Midwest Award

Marina Biotech Expands European and Canadian Patent Protection of Its SMARTICLES Nucleic Acid Delivery Technology

SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China

Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China

Threshold Pharmaceuticals Announces Presentation and Webcast at the Jefferies 2015 Healthcare Conference

SciClone to Present at Jefferies 2015 Global Healthcare Conference on June 3, 2015

Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2015 Financial Results

Theravance Biopharma, Inc. Reports First Quarter 2015 Financial Results

Corcept Therapeutics Announces First Quarter 2015 Results and Provides Corporate Update

Horizon Pharma plc Announces Waiver of Financing Proceeds Condition

Linkage Biosciences Partners With Italian Distributor

Genetic Technologies Announces: Additional Breast Health Centres to Begin Offering BREVAGenplus(R)

Threshold Pharmaceuticals to Host Analyst and Investor Day on April 24 in New York City

Service Menu

New here

Who is online